Powerful New Tools to Diagnosis Blood Cancers in Development
Scientists are using new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24 million people globally.
Category: Lymphoma
Lymphoma
Latest
Lymphoma
Latest
New Directions in Triple-Negative Breast Cancer Diagnostics
A novel PD-L1 assay advances the promise of precision medicine.
Lymphoma
Latest
January 2019 Product Spotlight: 2019 Emerging Technologies Showcase
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
NCI Awards $1.4 Million Grant to Advanced Cell Diagnostics
Under a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.
Read MorePathGroup Collaboration to Offer Genomic Profiling of Hematologic Malignancies
A new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read MoreTool Could Help Assessment of Hodgkin’s Lymphoma and Breast Cancer
A new study shows the MultiOmyx profile could improve disease assessment for both diseases using multiplex proteins.
Read More
Sequenta Expands Sample Types Accepted for ClonoSIGHT MRD Test for Leukemia, Lymphoma
Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.
Read More
Diagnovus Debuts Gene Expression Assay for Patients With Diffuse Large B-Cell Lymphoma
Assay can aid physicians in better risk stratification and treatment of patients with diffuse large B-cell lymphoma.
Read More
Sequenta Introduces ClonoSIGHT, Sequencing-Based MRD Test for Leukemia, Lymphoma
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.
Read MoreTesting for Lymphoma and Leukemia
With so many types of lymphoma, there’s a wide range of corresponding lab tests to detect their presence in patients. Here, CLP takes a look at testing for the most common type of lymphoma (diffuse large B-cell
Read More